Volume 9 Supplement 2

6th European Workshop on Immune-Mediated Inflammatory Diseases

Open Access

MCP-1, CCR2 and CCR5 polymorphisms in Tunisian patients with atopic asthma

  • Tarak Dhaouadi1,
  • Imen Sfar1,
  • Hajer Aounallah-Skhiri2,
  • Saloua Jendoubi-Ayed1,
  • Mohamed Amri1,
  • Hend Bouacha3,
  • Taieb Ben Abdallah1,
  • Khaled Ayed1 and
  • Yousr Gorgi1
Journal of Translational Medicine20119(Suppl 2):P10

https://doi.org/10.1186/1479-5876-9-S2-P10

Published: 23 November 2011

Background

Chemokines and their receptors play an important in the late inflammatory stage occurring in asthma.

Objective

We aimed to investigate polymorphisms of MCP-1 (CCL2), CCR2 and CCR5 which can modify qualitatively and/or quantitatively their production and thus influence both susceptibility to asthma and its clinical and biological features.

Patients and methods

MCP-1 (A/G -2518), CCR2 (+/64I), CCR5 (G/A -59029) and CCR5 (Δ32) polymorphisms were detected by PCR in 107 Tunisian patients with asthma and 169 healthy controls.

Results

We found no significant association between any of the four investigated polymorphisms and asthma. Nevertheless the haplotype MCP1AG/ CCR2+/+ was significantly less frequent in patients (20,5%) than in controls (32,5%) p=0,03 OR=0,54 95% CI: 0,29-0,98. While no difference observed in CCR2/CCR5 haplotypes between patients and controls.

Analysis of polymorpohisms with clinical and biological features showed a non significant decrease of the frequency of MCP-1G and CCR264I alleles in patients with severe disease, moreover the concomitant presence of MCP-1G/CCR264I alleles was less frequent in severe forms (4,34%) than in other patients (12%) but the difference was no longer significant p=0,27. No associations were observed between the four polymorphisms and the presence of atopic rhinitis or atopic conjunctivitis and an elevated rate of serum IgE over 200 UI/ml.

Conclusion

Polymorphisms of MCP-1 and its receptor CCR2 seem to be involved in disease-susceptibility to asthma in Tunisian; nevertheless they could be protective against its severe forms.

Authors’ Affiliations

(1)
Laboratory of Research in Renal Transplantation and Immunopathology (LR03SP01), Charles Nicolle Hospital, Tunis El Manar University
(2)
National Institute of Public Health
(3)
Pneumonology Dept, Charles Nicolle Hospital

Copyright

© Dhaouadi et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement